双J管结壳成分的临床研究
|
摘要
目的：用红外线光谱分析法确定和比较结石患者在无菌条件下放置的双J管晶体结壳与原发结石的组成成分。
方法：对2010年11月-2011年4月间322例患者的尿石和52例双J管结壳进行红外线光谱分析,322例为外科手术取出的上尿路结石,52例为上述结石患者在膀胱镜(或输尿管镜)下拔除的双J管结壳。结石患者放置双J管的平均时间是57天。
结果：结石患者的双J管结壳的成分有草酸钙(37例,其中13例草酸钙-磷灰石混合结石,3例草酸钙-无水尿酸结石),磷酸镁铵(3例),磷灰石(4例,其中3例为磷灰石-草酸钙混合结石),无水尿酸(8例)。结石患者原发结石成分有草酸钙(40例,其中14例草酸钙-磷灰石混合结石,4例草酸钙-无水尿酸结石),磷酸镁铵(2例),磷灰石(5例,其中4例为磷灰石-草酸钙混合结石),无水尿酸(5例)。
结论：双J管短期放置时间不影响结壳的发生及成分。草酸钙是结石患者双J管结壳的主要成分类型。原发结石和双J管晶体结壳的主要成分相似。结石患者双J管结壳平均重量76.5mg。当不能得到原发结石标本时,双J管结壳的红外线光谱分析不失为一种能预测结石成分的可靠方法。
Purpose:To determine the composition of crystalline encrustation on double J ureteral stent inserted under sterile conditions by infrared spectroscopy, in comparison with primary calculus in stone formers.
Methods:322 primary calculuses and 52 double J ureteral stent encrustations between November 2010 and April 2011 were collected and analyzed with infrared spectroscopy,322 upper tract urinary calculi from stone formers were surgically removed,52 double J ureteral stent encrustations from stone formers were removed by cystoscopy(or ureteroscope). The mean dwelling time was 57 days for the stone formers.
Results:The double J ureteral stent encrustations in stones formers are calcium oxalate(37, in 13 cases together with apatite and 3 cases together with uric acid), struvite(3), apatite(4,in 3 cases together with calcium oxalate), uric acid(8).It is also identified that the primary calculuses in stone formers are calcium oxalate(40, in 14 cases together with apatite and 4 cases together with uric acid), struvite(2), apatite(5, in 4 cases together with calcium oxalate), uric acid(5).
Conclusions:The short duration of stenting time does not influence the presence and composition of encrustation.Calcium oxalate is the predominant type of encrustation on double J ureteral stent in stone formers.Both the composition of primary calculus in stone former and crystalline encrustation on double J ureteral stent are similar. The mean weight of double J ureteral encrustation of stone formers was 76.5mg. Infrared spectroscopy analysis of double J ureteral stent encrustations is a reliable method of predicting stone composition when the stone cannot be retrieved.
方法：对2010年11月-2011年4月间322例患者的尿石和52例双J管结壳进行红外线光谱分析,322例为外科手术取出的上尿路结石,52例为上述结石患者在膀胱镜(或输尿管镜)下拔除的双J管结壳。结石患者放置双J管的平均时间是57天。
结果：结石患者的双J管结壳的成分有草酸钙(37例,其中13例草酸钙-磷灰石混合结石,3例草酸钙-无水尿酸结石),磷酸镁铵(3例),磷灰石(4例,其中3例为磷灰石-草酸钙混合结石),无水尿酸(8例)。结石患者原发结石成分有草酸钙(40例,其中14例草酸钙-磷灰石混合结石,4例草酸钙-无水尿酸结石),磷酸镁铵(2例),磷灰石(5例,其中4例为磷灰石-草酸钙混合结石),无水尿酸(5例)。
结论：双J管短期放置时间不影响结壳的发生及成分。草酸钙是结石患者双J管结壳的主要成分类型。原发结石和双J管晶体结壳的主要成分相似。结石患者双J管结壳平均重量76.5mg。当不能得到原发结石标本时,双J管结壳的红外线光谱分析不失为一种能预测结石成分的可靠方法。
Purpose:To determine the composition of crystalline encrustation on double J ureteral stent inserted under sterile conditions by infrared spectroscopy, in comparison with primary calculus in stone formers.
Methods:322 primary calculuses and 52 double J ureteral stent encrustations between November 2010 and April 2011 were collected and analyzed with infrared spectroscopy,322 upper tract urinary calculi from stone formers were surgically removed,52 double J ureteral stent encrustations from stone formers were removed by cystoscopy(or ureteroscope). The mean dwelling time was 57 days for the stone formers.
Results:The double J ureteral stent encrustations in stones formers are calcium oxalate(37, in 13 cases together with apatite and 3 cases together with uric acid), struvite(3), apatite(4,in 3 cases together with calcium oxalate), uric acid(8).It is also identified that the primary calculuses in stone formers are calcium oxalate(40, in 14 cases together with apatite and 4 cases together with uric acid), struvite(2), apatite(5, in 4 cases together with calcium oxalate), uric acid(5).
Conclusions:The short duration of stenting time does not influence the presence and composition of encrustation.Calcium oxalate is the predominant type of encrustation on double J ureteral stent in stone formers.Both the composition of primary calculus in stone former and crystalline encrustation on double J ureteral stent are similar. The mean weight of double J ureteral encrustation of stone formers was 76.5mg. Infrared spectroscopy analysis of double J ureteral stent encrustations is a reliable method of predicting stone composition when the stone cannot be retrieved.
引文
[1]Cheung MC,Lee F,Leung YL,Wong BB,Tam PC. A prospective randomized controlled trial on ureteral stenting after ureteroscopic holmium laser lithotripsy. J Urol.2003,169:1257-1260.
[2]Jeong H,Kwak C,Lee SE.Ureteric stenting after ureteroscopyfor ureteric stones:a prospective randomized study assessing symptoms and complications. BJU Int.2004, 93:1032-1035.
[3]Damiano R,Autorino R,Esposito C,et al.Stent positioning after ureteroscopy for urinary calculi:the question is still open. Eur Urol.2004,46:381-387.
[4]Damiano R, Oliva A, Esposito C, De Sio M, Autorino R,D" Armiento M. Early and late complications of double pigtail ureteral stent. Urol Int 2002,69:136-140.
[5]Quek ML, Dunn MD. Knot formation at the mid portion of an indwelling ureteral stent. J Urol 2002;168:1497.
[6]G. BITHELIS, M.D.,1N. BOUROPOULOS, Ph.D.,2E.N. LIATSIKOS, M.D.,'P. PERIMENIS, M.D.,'P.G KOUTSOUKOS, Ph.D.,3G.A. BARBALIAS, M.D.1 Assessment of Encrustations on Polyurethane Ureteral Stents.[J].JOURNAL OF ENDOUROLOGY.2004,18(6):550-556.
[7]Tiselius HGEpidemiology and medical management of stone disease. BJU Int 2003,91:758-767.
[8]Pak CY, Heller HJ, Pearle MS, et al:Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol.2003,169:465-469.
[9]Pak CY, Poindexter JR, Adams-Huet B, et al:Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med.2003,115: 26-32.
[10]Traxer O, Huet B, Poindexter J, et al:Effect of ascorbic acid consumption on urinary stone risk factors. J Urol.2003,170:397-401.
[11]Woolfson AD, Gorman SP, McCafferty DF. Characterisation of encrustation on long-term indwelling urinary catheters. Pharmacotherapy.1991,11:287.
[12]Youness Ahallal, MD, Abdelhak Khallouk, PhD, Mohammed Jamal El Fassi, PhD,Moulay Hassan Farih, PhD.Risk Factor Analysis and Management of Ureteral Double-J Stent Complications. Rev Urol.2010,12:147-151.
[13]SIMON BARIOL, M.B.B.S., B.Sc. (Med), et al. Comparison of Urinary Stone and Stent Encrustation:Biochemical Analysis. JOURNAL OF ENDOUROLOGY.2003. 17(9),741-743.
[14]Lam JS, Gupta M. Tips and tricks for the management of retained ureteral stents. J Endourol.2002,16:733-741.
[15]Borboroglu PG, Kane CJ. Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol.2000;164:648-650.
[16]Farsi HM, Mosli HA, Al-Zemaity MF, Bahnassy AA, Alvarez M:Bacteriuria and colonization of double pigtail ureteral stents:Long term experience with 237 patients. J Endourol.1995,6:469-472.
[17]Goldfarb DS. Increasing prevalence of kidney stones in the United States. Kidney Int,2003,63:1951-1952
[18]Bihl G, Meyers A. Recurrent renal stone disease-advances in pathogenesis and clinical management.Lancet,2001,358:651-656
[19]Ouyang JM. Combined analyses of mixed urinary stones by XPS and XRD. Spectroscopy and Spectral Analysis,2003,23(2):391～395.
[20]孙西钊,郭宏骞,叶章群.尿石的成因.临床泌尿外科杂志.2003.(18)6：321-326.
[21]Pak CY, Adams-Huet B, Poindexter JR,et al.Rapid Communication:Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int.2004, 66:2032-7.
[22]黄志杰,李君君,何节玉,欧阳健明.草酸钙结石患者尿液中纳米级和微米级晶体研究.光谱学与光谱分析.2010,30(7)：1913-1917
[23]Tunney MM, Jones DS, Gorman PS. Biofilm and biofilm-related encrustation of urinary tract devices. Methods Enzymol.1999,310:558-566.
[24]Santin M, Motta A, Denyer SP, et al. Effect of the urine conditioning film on ureteral stent encrustation and characterization of its protein composition. Biomaterials 1999,20:1245-1251.
[25]Wollin TA,Tieszer C, Riddell JV, et al. Bacterial biofilm formation, encrustation and antibiotic adsorption to ureteral stents indwelling in humans.J Endourol.1998, 12:101-111.
[26]PF Keane, MC Bonner, SR Johnston,et al. Characterization of biofilm and encrustation on ureteric stents in vivo. British Journal of Urology.1994,73:687-691.
[27]Jones DS, Gorman SP, McCafferty DF,et al. A comparative study of the effects of three non-antibiotic antimicrobial agents on the surface hydrophobicity of certain microorganisms. J Appl Bacteriol.1991,71:218-27.
[28]Gorman SP, Mawhinney WM, Adair CG. Issouckis M. Confocal scanning laser microscopy of CAPD catheter surface microrugosity in relation to recurrent peritonitis. J Med Microbiol.1993,38:411-17.
[29]Mawhinney WM, Adair CG, Gorman SP. Factors influencing the adherence of microbial pathogens to CAPD catheters. Pharmacotherapy.1992,12:253
[30]Keane PF, Bonner MC, Johnston SR, et al. Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol.1994,73:687-691.
[31]Greg L.Shaw-Simon K.Choong-Christopher Fry.Encrustation of biomaterials in the urinary tract.Urol Res.2005,33:17-22.
[32]Daudon M, Dore JC, Jungers P, et al.Changes in stone composition according to age and gender of patients:a multi-variate epidemiological approach.Urol Res.2004,32: 241-247.
[33]Bowsher WG,Crocker P, Ramsay JWA, Whitfield HN. Single urine sample diagnosis: Anew concept in stone analysis. Br J Urol.1990,65:236.
[34]Traxer O, Huet B, Poindexter J, et al. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol.2003,170:397-401.
[35]Siener R, Glatz S, Nicolay C, et al. Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur Urol.2003,44:467-474.
[1]Damiano R, Oliva A, Esposito C, De Sio M, Autorino R,D'Armiento M. Early and late complications of double pigtail ureteral stent. Urol Int 2002, 69:136-140.
[2]Quek ML, Dunn MD. Knot formation at the mid portion of an indwelling ureteral stent. J Urol.2002,168:1497.
[3]Dyer RB,Chen MY,Zagoria RJ,et al.Complications of ureteral stent placement. Radiographics.2002,22:1005-1022.
[4]Cheung MC,Lee F,Leung YL,Wong BB,Tam PC. A prospective randomized controlled trial on ureteral stenting after ureteroscopic holmium laser lithotripsy. J Urol.2003,169:1257-1260.
[5]Jeong H,Kwak C,Lee SE.Ureteric stenting after ureteroscopyfor ureteric stones: a prospective randomized study assessing symptoms and complications. BJU Int.2004,93:1032-1035.
[6]Damiano R,Autorino R,Esposito C,et al.Stent positioning after ureteroscopy for urinary calculi:the question is still open. Eur Urol.2004,46:381-387.
[7]G. BITHELIS, M.D.,'N. BOUROPOULOS, Ph.D.,2E.N. LIATSIKOS, M.D.,'P. PERIMENIS, M.D.,'P.G. KOUTSOUKOS, Ph.D.,3G.A. BARBALIAS, M.D.1 Assessment of Encrustations on Polyurethane Ureteral Stents.[J].JOURNAL OFENDOUROLOGY.2004,18(6):550-556.
[8]Tiselius HG,Epidemiology and medical management of stone disease. BJU Int. 2003,91:758-767.
[9]Pak CY, Heller HJ, Pearle MS, et al:Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol.2003,169:465-469.
[10]Pak CY, Poindexter JR, Adams-Huet B, et al:Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med.2003,115: 26-32.
[11]Traxer O, Huet B, Poindexter J, et al:Effect of ascorbic acid consumption on urinary stone risk factors. J Urol.2003,170:397-401.
[12]Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically.JUro/.1967,97:840-4.
[13]Finney RP. Experience with new double J ureteral catheter stent. J Urol 1978, 120:678-681.
[14]Hepperlen TK,Mardis HK.Pigtail stent termed means of lessening ureteral surgery.Trends Clin Urol,1978,1:405.
[15]Montie JE,Stewart BH,Levin HS.Intravasal stents for vasovasostomy in canine subjects.Fertil Steril.1973,24:877-883.
[16]Payne SR, Ramsay JW.The effects of double J stents on renal pelvic dynamics in the pig. J Urol.1988,140:637-641
[17]Roos R, Lykoudis PS. The fluid mechanics of the ureter with an inserted catheter. J Fluid Mech.1971,46:265-271
[18]Roos R, Lykoudis PS. The fluid mechanics of the ureter with an inserted catheter. J Fluid Mech.1971,46:265-271
[19]Hubner WA, Plas EG, Stoller ML. The double-J ureteral stent:in vivo and in vitro flow studies.J urol.1992,148(2 Pt 1):278-280
[20]Lennon GM, Thornhill JA, Grainger R, et al. Double pigtail ureteric stent versus percutaneous nephrostomy:Effects on stone transit and ureteric motility. Eur Urol.1997,31:24-29
[21]Damiano R, Oliva A, Esposito C, De Sio M, Autorino R,D'Armiento M. Early and late complications of double pigtail ureteral stent. Urol Int 2002,69: 136-140.
[22]杜广辉,杨为民,庄乾元,叶章群,等.双J管在上尿路梗阻性疾病中的应用及其并发症.中华泌尿外科杂志,2001,22(2)：92-94.
[23]Youness Ahallal, MD, Abdelhak Khallouk, PhD, Mohammed Jamal El Fassi, PhD,Moulay Hassan Farih, PhD.Risk Factor Analysis and Management of Ureteral Double-J Stent Complications. Rev Urol.2010,12:147-151.
[24]SIMON BARIOL, M.B.B.S., B.Sc. (Med), et al. Comparison of Urinary Stone and Stent Encrustation:Biochemical Analysis. JOURNAL OF ENDOUR-OLOGY.2003.17(9),741-743.
[25]Lam JS, Gupta M. Tips and tricks for the management of retained ureteral stents. J Endourol.2002,16:733-741.
[26]Borboroglu PG, Kane CJ. Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol.2000; 164:648-650.
[27]Farsi HM, Mosli HA, Al-Zemaity MF, Bahnassy AA, Alvarez M:Bacteriuria and colonization of double pigtail ureteral stents:Long term experience with 237 patients. J Endourol.1995,6:469-472.
[28]Tunney MM, Jones DS, Gorman PS. Biofilm and biofilm-related encrustation of urinary tract devices. Methods Enzymol.1999,310:558-566.
[29]Santin M, Motta A, Denyer SP, et al. Effect of the urine conditioning film on ureteral stent encrustation and characterization of its protein composition. Biomaterials 1999,20:1245-1251.
[30]Wollin TA,Tieszer C, Riddell JV, et al. Bacterial biofilm formation, encrustation and antibiotic adsorption to ureteral stents indwelling in humans.J Endourol.1998,12:101-111.
[31]Keane PF, Bonner MC, Johnston SR, et al. Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol.1994,73:687-691.
[32]Pak CY, Adams-Huet B, Poindexter JR,et al.Rapid Communication:Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int.2004,66:2032-7.
[33]黄志杰,李君君,何节玉,欧阳健明*.草酸钙结石患者尿液中纳米级和微米级晶体研究.光谱学与光谱分析.2010,30(7)：1913-1917.
[34]Tieszer C, Reid G, Denstedt JD. Conditioning film deposition on ureteral stents after implantation.J Urol.1998,160:876-881.
[35]Sidhu H, Holmes RP, Allison MJ, et al. Direct quantifications of the enteric bacterium Oxalobacter formingens in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol.1999,37:1503-1509.
[36]Greg L.Shaw-Simon K.Choong·Christopher Fry.Encrustation of biomaterials in the urinary tract.Urol Res.2005,33:17-22.
[37]Reid G,Denstedt JD,Kang YS et al.Microbial adhesion and biofilm formation on ureteral stents in vitro and invivo.J Urol.1992,148:1592
[38]Stickler DJ,Clayton CL,Harber MJ et al.Pseudomonas aeruginosa and long-term indwelling bladder catheters.Arch Phys Med Rehabil.1988,69:25.
[39]Morris NS,Stickler DJ,McLean RJ.The development of bacterial biofilms on indwelling urethral catheters.World J Urol.1999,17:345.
[40]Ecke TH, Hallmann S, Ruttloff J. Multimodal stone therapy for two forgotten and encrusted ureteral stents:a case report. Cases J..2009,2:106.
[41]Smet G, Vandeursen H, Baert L. Extracorporeal shock wave lithotripsy for calcified ureteral catheter. Urol Int.1991,46:211-212.
[42]Cass AS, Kavaney PB, Smith CL. Multiple cystine stone formations on an indwelling ureteral stent treated by extracorporeal shock wave lithotripsy. J Urol.1992,147:1076-1078.
[43]Killeen KP, Bihrle W Ⅲ. Ureteroscopic removal of retained ureteral Double-J stents. Urology.1990,35:354-359.
[44]Bukkapatnam R, Seigne J, Helal M.1-step removal of encrusted retained ureteral stents. J Urol.2003,170:1111-1114.
[45]Somers WJ. Management of forgotten or retained indwelling ureteral stents. Urology.1996,47:431-435.
[46]Borboroglu PG, Kane CJ. Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol.2000,164:648-650.
[47]Mohan-Pillai K, Keeley FX Jr, Moussa SA, Smith G, Tolley DA. Endourological management of severely encrusted ureteral stents.J Endourol.1999,13:377-379.
[48]Schulze KA, Wettlaufer IN, Oldani G. Encrustation and stone formation. Complication of indwelling ureteral stents. Urology.1985,25:616-619.
[49]Chew B, Knudsen BE, Denstedt JD. The use of stents in contemporary urology. CurrOpin Urol.2004,14(2):111-115.
[50]Liatsikos E,Kallidonis P,Stolzenburg JU,Karnabatidis D.Ureteral stents:past, present and future.Expert Rev Med Devices.2009,6:313-324.
[51]Venkatesan N,Shroff S,Jayachandran K,Doble M.Polymers as ureteral stents.J Endourol.2010,24:191-198.
[52]Beiko DT.Knudsen BE,Denstedt JD.Advances in ureteral stent design.J Endourol.2003,17:195-199.
[53]Morris NS,Stickler DJ,Winters C.Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms?Br J Urol.1997,80:58
[54]Jones DS, Garvin CP,GormSP.Relationship between biomedical catheter surface properties and lubricity as determined using textural analysis and multiple regression analysis.2004,25(7-8):1421-1428.
[55]Kulkarni R,Bellamy E.Nickel-titanium shape memory alloy Memokath 051 ureteral stent for managing long-term ureteral obstruction:4-year experience.J Urol.2001,166(5):1750-1754.
[56]Thijssen AM, Millward F, Mai KT. Ureteral response to the placement of metallic stents:An animal model. J Urol.1994,151:268-270
[57]Desgrandchamps F, Tuhschmid Y, Cochand-Priollet B, et al. Experimental study of Wallstent self-expandable metal stent in ureteral implantation. J Endourol.1995,9:477-481
[58]Barbalias GA,Liatsikos EN,Kalogeropoulou C,et al.Externally coated ureteral metallic stents:an unfavorable clinical experience.Eur Urol.2002,42 (3): 276-280.
[59]宋毅,李鸣,那彦群,等.记忆合金网状支架治疗输尿管狭窄的长期随访报告.中华医学杂志,2005,85(42)：2992-2994.
[60]Bhang SH,Lim JS,Choi CY,et al.The behavior of neural stemcells on biodegradable synthetic polymers.Journal of Biomaterials Science. Polymer Edition.2007,18(2):223-239.
[61]Lawrence BJ,Maase EL,Lin HK,et al.Multilayer composite scaffolds with mechanical properties similar to small intestinal submucosa.Journal of Biomedical Materials Research.2009,88(3):634-643.
[62]Gregory S,Zhang R,Lee M,et al.Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite-Biomaterials.2009,30(13):3259-3270.
[63]Park K,Ju YM,Son JS,et al.Surface modification of biodegradable electrospun nanofiber scaffolds and their interaction with fibroblasts. Journal of Biomaterials Science.Polymer Edition.2007,18(4):369-382.
[64]Manuel JS,Iisette G,Juan L,et al.Protein-loaded PLGA-PEO blend nanoparticles:encapsulation,release and degradation characteristics.Colloid Polym Sci.2010,288:141-150.
[65]Jeong SI,Lee AY,Lee YM,et al.Electrospun gelatin/poly(L-lactide-co-ε-caprolactone) nanofibers for mechanically functional tissue-engineering scaffolds.Journal of Biomaterials Science. Polymer Edition.2008,19(3): 339-357.
[66]Hadaschik BA,Paterson RF,FazliL,et al.Investigation of a novel degradable ureteral stent in a porcine model. J Urol.2008,180(3):1161-1166.
[67]Beiko DT,Knudsen BE,Denstedt JD. Advances in ureteral stent design J Endourol.2003,17(4):195-199.
[68]Lumiaho J.Heino A, Kauppinen T,et al.Drainage and antireflux characteristics of a biodegradable self-reinforced, self-expandingX-ray-positive poly-L, D-lactide spiral partial ureteral stent:an experimental study.J Endourol.2007, 21(12):1559-1564.
[69]Olweny EO,Portis AJ,Sundaram CP,et al.Evaluation of achronic indwelling prototype mesh ureteral stent in a porcine model.Urology.2000,56(5):857-862.
[70]Liatsikos EN,Hom D,Dinlenc CZ,et al.Tail Stent versusreentry tube:A randomized comparison after percutaneous stone extraction.Urology,2002,59 (1):15-19.
[71]Mardis HK.Standard specification for ureteral stents:A comparative evaluation of newer devices.J Urol,2001,165(suppl):362.
[72]Taylor WN,McDougall IT.Minimally invasive ureteral stent retrieval.J Urol.2002,168(5):2020-2023.
[73]Ecke TH,Bartel P,Hallmann S,Ruttloff J.Evaluation of symptoms and patients's comfort for JJ-ureteral stents with and without antireflux-membrane valve. Urology.2010,75:212-216.
[74]Beiko DT, Knudsen BE. Watterson JD, Cadieux PA, Reid G, Denstedt JD. Urinary tract biomaterials. J Urol.2004,171:2438-2444.
[75]Chew BH, Denstedt JD. Technology inside:novel ureteral stent materials and designs. Nat Clin Pract Urol.2004,1:44-48.
[76]Tolley D.Ureteric stents, far from ideal. Lancet.2000,356:872-873.
[77]Watterson JD, Cadieux P, Denstedt JD. Ureteral stents:which, when, and why? AUA Update Series.2002,21(16):122.
[78]Tunney MM, Gorman SP. Evaluation of a poly(vinyl pyrrolidone)-coated biomaterial for urological use. Biomaterials.2002,23:4601-4608.
[79]Stickler DJ, Evans A, Morris N, et al. Strategies for the control of catheter encrustation. Int J Antimicrob Agents.2002,19:499-506.
[80]Riedl CR, Witkowski M, Plas E, Plueger H. Heparin coating reduces encrustation of ureteral stents:A preliminary report. Int J Antimicrob Agents. 2002,19:507-510.
[81]Watterson JD, Cadieux PA, Beiko DT, et al.Oxalatedegrading enzymes from Oxalobacter formigenes:a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol.2003,17:269-274.
[82]Laube N, Klienen L, Bradenahl J, et al. Diamond-like carbon coatings on ureteral stents-a new strategy for decreasing the formation of crystalline bacterial bioilm? J Urol.2007,177:1923-1927.
[83]Cormio L,Vuopio-Varkila J,Siitonen A etal.Bacterial adhesion and biofilm formation on various double-J stents in vivo and in vitro.Scand J Urol Nephro.1996,130:19
[84]Moulinier F.Comparison of biomaterial urinary encrustation in human implantation and in three experimental models.Br J U [Suppl].1997,80:302.
[85]Tunney MM,Keane PF,Jones DS et al.Comparative assessment of ureteral stent biomaterial encrustation.Biomaterials.1996,17:1541.
[86]Tunney MM,Bonner MC,Keane PF et al.Development of a model for assessment of biomaterial encrustation in the upper urinary tract.Biomaterials. 1996,17:1025.
[87]Tunney MM,Keane PF,Gorman SP.Assessment of urinary tract biomaterial encrustation using a modified Robbins device continuous flow model.J Biomed Mater Res.1997,38:87.
[88]Hedelin H,Grenabo L,Pettersson S.The effects of glycosaminoglycans, pyrophosphate and allopurinol treatment on urease-induced crystallization in vitro.UrolRes.1986,14:305.
[89]Wang YH,Grenabo L,Hedelin H et al.Citrateand urease-induced crystallization in synthetic and human urine.Urol Res.1993,21:109.
[90]Hedelin H,Grenabo L,Hugosson J et al.The influence of zinc and citrate on urease-induced urine crystallisation.Urol Res.1989,17:177.
[91]Choong SK,Wood S,Whitfield HN.A model to quantify encrustation on ureteric stents,urethral catheters and polymers intended for urological use.BJU Int.2000, 86:414.
[92]Painter DJ,Stickler DJ.A model to quantify encrustation on ureteric stents,urethral catheters and polymers intended for urological use.BJU Int.2001,87:716.
[93]Tieszer C,Reid G,Denstedt J.XPS and SEM detection of surface changes on 64 ureteral stents after human usage. J Biomed Mater Res.1998,43:321.
[94]Wood S.A novel method to measure ionized Mg2+and NH4+in undiluted urine:implications for stone formation.BJU Int.1997,84:156.
[2]Jeong H,Kwak C,Lee SE.Ureteric stenting after ureteroscopyfor ureteric stones:a prospective randomized study assessing symptoms and complications. BJU Int.2004, 93:1032-1035.
[3]Damiano R,Autorino R,Esposito C,et al.Stent positioning after ureteroscopy for urinary calculi:the question is still open. Eur Urol.2004,46:381-387.
[4]Damiano R, Oliva A, Esposito C, De Sio M, Autorino R,D" Armiento M. Early and late complications of double pigtail ureteral stent. Urol Int 2002,69:136-140.
[5]Quek ML, Dunn MD. Knot formation at the mid portion of an indwelling ureteral stent. J Urol 2002;168:1497.
[6]G. BITHELIS, M.D.,1N. BOUROPOULOS, Ph.D.,2E.N. LIATSIKOS, M.D.,'P. PERIMENIS, M.D.,'P.G KOUTSOUKOS, Ph.D.,3G.A. BARBALIAS, M.D.1 Assessment of Encrustations on Polyurethane Ureteral Stents.[J].JOURNAL OF ENDOUROLOGY.2004,18(6):550-556.
[7]Tiselius HGEpidemiology and medical management of stone disease. BJU Int 2003,91:758-767.
[8]Pak CY, Heller HJ, Pearle MS, et al:Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol.2003,169:465-469.
[9]Pak CY, Poindexter JR, Adams-Huet B, et al:Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med.2003,115: 26-32.
[10]Traxer O, Huet B, Poindexter J, et al:Effect of ascorbic acid consumption on urinary stone risk factors. J Urol.2003,170:397-401.
[11]Woolfson AD, Gorman SP, McCafferty DF. Characterisation of encrustation on long-term indwelling urinary catheters. Pharmacotherapy.1991,11:287.
[12]Youness Ahallal, MD, Abdelhak Khallouk, PhD, Mohammed Jamal El Fassi, PhD,Moulay Hassan Farih, PhD.Risk Factor Analysis and Management of Ureteral Double-J Stent Complications. Rev Urol.2010,12:147-151.
[13]SIMON BARIOL, M.B.B.S., B.Sc. (Med), et al. Comparison of Urinary Stone and Stent Encrustation:Biochemical Analysis. JOURNAL OF ENDOUROLOGY.2003. 17(9),741-743.
[14]Lam JS, Gupta M. Tips and tricks for the management of retained ureteral stents. J Endourol.2002,16:733-741.
[15]Borboroglu PG, Kane CJ. Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol.2000;164:648-650.
[16]Farsi HM, Mosli HA, Al-Zemaity MF, Bahnassy AA, Alvarez M:Bacteriuria and colonization of double pigtail ureteral stents:Long term experience with 237 patients. J Endourol.1995,6:469-472.
[17]Goldfarb DS. Increasing prevalence of kidney stones in the United States. Kidney Int,2003,63:1951-1952
[18]Bihl G, Meyers A. Recurrent renal stone disease-advances in pathogenesis and clinical management.Lancet,2001,358:651-656
[19]Ouyang JM. Combined analyses of mixed urinary stones by XPS and XRD. Spectroscopy and Spectral Analysis,2003,23(2):391～395.
[20]孙西钊,郭宏骞,叶章群.尿石的成因.临床泌尿外科杂志.2003.(18)6：321-326.
[21]Pak CY, Adams-Huet B, Poindexter JR,et al.Rapid Communication:Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int.2004, 66:2032-7.
[22]黄志杰,李君君,何节玉,欧阳健明.草酸钙结石患者尿液中纳米级和微米级晶体研究.光谱学与光谱分析.2010,30(7)：1913-1917
[23]Tunney MM, Jones DS, Gorman PS. Biofilm and biofilm-related encrustation of urinary tract devices. Methods Enzymol.1999,310:558-566.
[24]Santin M, Motta A, Denyer SP, et al. Effect of the urine conditioning film on ureteral stent encrustation and characterization of its protein composition. Biomaterials 1999,20:1245-1251.
[25]Wollin TA,Tieszer C, Riddell JV, et al. Bacterial biofilm formation, encrustation and antibiotic adsorption to ureteral stents indwelling in humans.J Endourol.1998, 12:101-111.
[26]PF Keane, MC Bonner, SR Johnston,et al. Characterization of biofilm and encrustation on ureteric stents in vivo. British Journal of Urology.1994,73:687-691.
[27]Jones DS, Gorman SP, McCafferty DF,et al. A comparative study of the effects of three non-antibiotic antimicrobial agents on the surface hydrophobicity of certain microorganisms. J Appl Bacteriol.1991,71:218-27.
[28]Gorman SP, Mawhinney WM, Adair CG. Issouckis M. Confocal scanning laser microscopy of CAPD catheter surface microrugosity in relation to recurrent peritonitis. J Med Microbiol.1993,38:411-17.
[29]Mawhinney WM, Adair CG, Gorman SP. Factors influencing the adherence of microbial pathogens to CAPD catheters. Pharmacotherapy.1992,12:253
[30]Keane PF, Bonner MC, Johnston SR, et al. Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol.1994,73:687-691.
[31]Greg L.Shaw-Simon K.Choong-Christopher Fry.Encrustation of biomaterials in the urinary tract.Urol Res.2005,33:17-22.
[32]Daudon M, Dore JC, Jungers P, et al.Changes in stone composition according to age and gender of patients:a multi-variate epidemiological approach.Urol Res.2004,32: 241-247.
[33]Bowsher WG,Crocker P, Ramsay JWA, Whitfield HN. Single urine sample diagnosis: Anew concept in stone analysis. Br J Urol.1990,65:236.
[34]Traxer O, Huet B, Poindexter J, et al. Effect of ascorbic acid consumption on urinary stone risk factors. J Urol.2003,170:397-401.
[35]Siener R, Glatz S, Nicolay C, et al. Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients. Eur Urol.2003,44:467-474.
[1]Damiano R, Oliva A, Esposito C, De Sio M, Autorino R,D'Armiento M. Early and late complications of double pigtail ureteral stent. Urol Int 2002, 69:136-140.
[2]Quek ML, Dunn MD. Knot formation at the mid portion of an indwelling ureteral stent. J Urol.2002,168:1497.
[3]Dyer RB,Chen MY,Zagoria RJ,et al.Complications of ureteral stent placement. Radiographics.2002,22:1005-1022.
[4]Cheung MC,Lee F,Leung YL,Wong BB,Tam PC. A prospective randomized controlled trial on ureteral stenting after ureteroscopic holmium laser lithotripsy. J Urol.2003,169:1257-1260.
[5]Jeong H,Kwak C,Lee SE.Ureteric stenting after ureteroscopyfor ureteric stones: a prospective randomized study assessing symptoms and complications. BJU Int.2004,93:1032-1035.
[6]Damiano R,Autorino R,Esposito C,et al.Stent positioning after ureteroscopy for urinary calculi:the question is still open. Eur Urol.2004,46:381-387.
[7]G. BITHELIS, M.D.,'N. BOUROPOULOS, Ph.D.,2E.N. LIATSIKOS, M.D.,'P. PERIMENIS, M.D.,'P.G. KOUTSOUKOS, Ph.D.,3G.A. BARBALIAS, M.D.1 Assessment of Encrustations on Polyurethane Ureteral Stents.[J].JOURNAL OFENDOUROLOGY.2004,18(6):550-556.
[8]Tiselius HG,Epidemiology and medical management of stone disease. BJU Int. 2003,91:758-767.
[9]Pak CY, Heller HJ, Pearle MS, et al:Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol.2003,169:465-469.
[10]Pak CY, Poindexter JR, Adams-Huet B, et al:Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med.2003,115: 26-32.
[11]Traxer O, Huet B, Poindexter J, et al:Effect of ascorbic acid consumption on urinary stone risk factors. J Urol.2003,170:397-401.
[12]Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically.JUro/.1967,97:840-4.
[13]Finney RP. Experience with new double J ureteral catheter stent. J Urol 1978, 120:678-681.
[14]Hepperlen TK,Mardis HK.Pigtail stent termed means of lessening ureteral surgery.Trends Clin Urol,1978,1:405.
[15]Montie JE,Stewart BH,Levin HS.Intravasal stents for vasovasostomy in canine subjects.Fertil Steril.1973,24:877-883.
[16]Payne SR, Ramsay JW.The effects of double J stents on renal pelvic dynamics in the pig. J Urol.1988,140:637-641
[17]Roos R, Lykoudis PS. The fluid mechanics of the ureter with an inserted catheter. J Fluid Mech.1971,46:265-271
[18]Roos R, Lykoudis PS. The fluid mechanics of the ureter with an inserted catheter. J Fluid Mech.1971,46:265-271
[19]Hubner WA, Plas EG, Stoller ML. The double-J ureteral stent:in vivo and in vitro flow studies.J urol.1992,148(2 Pt 1):278-280
[20]Lennon GM, Thornhill JA, Grainger R, et al. Double pigtail ureteric stent versus percutaneous nephrostomy:Effects on stone transit and ureteric motility. Eur Urol.1997,31:24-29
[21]Damiano R, Oliva A, Esposito C, De Sio M, Autorino R,D'Armiento M. Early and late complications of double pigtail ureteral stent. Urol Int 2002,69: 136-140.
[22]杜广辉,杨为民,庄乾元,叶章群,等.双J管在上尿路梗阻性疾病中的应用及其并发症.中华泌尿外科杂志,2001,22(2)：92-94.
[23]Youness Ahallal, MD, Abdelhak Khallouk, PhD, Mohammed Jamal El Fassi, PhD,Moulay Hassan Farih, PhD.Risk Factor Analysis and Management of Ureteral Double-J Stent Complications. Rev Urol.2010,12:147-151.
[24]SIMON BARIOL, M.B.B.S., B.Sc. (Med), et al. Comparison of Urinary Stone and Stent Encrustation:Biochemical Analysis. JOURNAL OF ENDOUR-OLOGY.2003.17(9),741-743.
[25]Lam JS, Gupta M. Tips and tricks for the management of retained ureteral stents. J Endourol.2002,16:733-741.
[26]Borboroglu PG, Kane CJ. Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol.2000; 164:648-650.
[27]Farsi HM, Mosli HA, Al-Zemaity MF, Bahnassy AA, Alvarez M:Bacteriuria and colonization of double pigtail ureteral stents:Long term experience with 237 patients. J Endourol.1995,6:469-472.
[28]Tunney MM, Jones DS, Gorman PS. Biofilm and biofilm-related encrustation of urinary tract devices. Methods Enzymol.1999,310:558-566.
[29]Santin M, Motta A, Denyer SP, et al. Effect of the urine conditioning film on ureteral stent encrustation and characterization of its protein composition. Biomaterials 1999,20:1245-1251.
[30]Wollin TA,Tieszer C, Riddell JV, et al. Bacterial biofilm formation, encrustation and antibiotic adsorption to ureteral stents indwelling in humans.J Endourol.1998,12:101-111.
[31]Keane PF, Bonner MC, Johnston SR, et al. Characterization of biofilm and encrustation on ureteric stents in vivo. Br J Urol.1994,73:687-691.
[32]Pak CY, Adams-Huet B, Poindexter JR,et al.Rapid Communication:Relative effect of urinary calcium and oxalate on saturation of calcium oxalate. Kidney Int.2004,66:2032-7.
[33]黄志杰,李君君,何节玉,欧阳健明*.草酸钙结石患者尿液中纳米级和微米级晶体研究.光谱学与光谱分析.2010,30(7)：1913-1917.
[34]Tieszer C, Reid G, Denstedt JD. Conditioning film deposition on ureteral stents after implantation.J Urol.1998,160:876-881.
[35]Sidhu H, Holmes RP, Allison MJ, et al. Direct quantifications of the enteric bacterium Oxalobacter formingens in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol.1999,37:1503-1509.
[36]Greg L.Shaw-Simon K.Choong·Christopher Fry.Encrustation of biomaterials in the urinary tract.Urol Res.2005,33:17-22.
[37]Reid G,Denstedt JD,Kang YS et al.Microbial adhesion and biofilm formation on ureteral stents in vitro and invivo.J Urol.1992,148:1592
[38]Stickler DJ,Clayton CL,Harber MJ et al.Pseudomonas aeruginosa and long-term indwelling bladder catheters.Arch Phys Med Rehabil.1988,69:25.
[39]Morris NS,Stickler DJ,McLean RJ.The development of bacterial biofilms on indwelling urethral catheters.World J Urol.1999,17:345.
[40]Ecke TH, Hallmann S, Ruttloff J. Multimodal stone therapy for two forgotten and encrusted ureteral stents:a case report. Cases J..2009,2:106.
[41]Smet G, Vandeursen H, Baert L. Extracorporeal shock wave lithotripsy for calcified ureteral catheter. Urol Int.1991,46:211-212.
[42]Cass AS, Kavaney PB, Smith CL. Multiple cystine stone formations on an indwelling ureteral stent treated by extracorporeal shock wave lithotripsy. J Urol.1992,147:1076-1078.
[43]Killeen KP, Bihrle W Ⅲ. Ureteroscopic removal of retained ureteral Double-J stents. Urology.1990,35:354-359.
[44]Bukkapatnam R, Seigne J, Helal M.1-step removal of encrusted retained ureteral stents. J Urol.2003,170:1111-1114.
[45]Somers WJ. Management of forgotten or retained indwelling ureteral stents. Urology.1996,47:431-435.
[46]Borboroglu PG, Kane CJ. Current management of severely encrusted ureteral stents with a large associated stone burden. J Urol.2000,164:648-650.
[47]Mohan-Pillai K, Keeley FX Jr, Moussa SA, Smith G, Tolley DA. Endourological management of severely encrusted ureteral stents.J Endourol.1999,13:377-379.
[48]Schulze KA, Wettlaufer IN, Oldani G. Encrustation and stone formation. Complication of indwelling ureteral stents. Urology.1985,25:616-619.
[49]Chew B, Knudsen BE, Denstedt JD. The use of stents in contemporary urology. CurrOpin Urol.2004,14(2):111-115.
[50]Liatsikos E,Kallidonis P,Stolzenburg JU,Karnabatidis D.Ureteral stents:past, present and future.Expert Rev Med Devices.2009,6:313-324.
[51]Venkatesan N,Shroff S,Jayachandran K,Doble M.Polymers as ureteral stents.J Endourol.2010,24:191-198.
[52]Beiko DT.Knudsen BE,Denstedt JD.Advances in ureteral stent design.J Endourol.2003,17:195-199.
[53]Morris NS,Stickler DJ,Winters C.Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms?Br J Urol.1997,80:58
[54]Jones DS, Garvin CP,GormSP.Relationship between biomedical catheter surface properties and lubricity as determined using textural analysis and multiple regression analysis.2004,25(7-8):1421-1428.
[55]Kulkarni R,Bellamy E.Nickel-titanium shape memory alloy Memokath 051 ureteral stent for managing long-term ureteral obstruction:4-year experience.J Urol.2001,166(5):1750-1754.
[56]Thijssen AM, Millward F, Mai KT. Ureteral response to the placement of metallic stents:An animal model. J Urol.1994,151:268-270
[57]Desgrandchamps F, Tuhschmid Y, Cochand-Priollet B, et al. Experimental study of Wallstent self-expandable metal stent in ureteral implantation. J Endourol.1995,9:477-481
[58]Barbalias GA,Liatsikos EN,Kalogeropoulou C,et al.Externally coated ureteral metallic stents:an unfavorable clinical experience.Eur Urol.2002,42 (3): 276-280.
[59]宋毅,李鸣,那彦群,等.记忆合金网状支架治疗输尿管狭窄的长期随访报告.中华医学杂志,2005,85(42)：2992-2994.
[60]Bhang SH,Lim JS,Choi CY,et al.The behavior of neural stemcells on biodegradable synthetic polymers.Journal of Biomaterials Science. Polymer Edition.2007,18(2):223-239.
[61]Lawrence BJ,Maase EL,Lin HK,et al.Multilayer composite scaffolds with mechanical properties similar to small intestinal submucosa.Journal of Biomedical Materials Research.2009,88(3):634-643.
[62]Gregory S,Zhang R,Lee M,et al.Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite-Biomaterials.2009,30(13):3259-3270.
[63]Park K,Ju YM,Son JS,et al.Surface modification of biodegradable electrospun nanofiber scaffolds and their interaction with fibroblasts. Journal of Biomaterials Science.Polymer Edition.2007,18(4):369-382.
[64]Manuel JS,Iisette G,Juan L,et al.Protein-loaded PLGA-PEO blend nanoparticles:encapsulation,release and degradation characteristics.Colloid Polym Sci.2010,288:141-150.
[65]Jeong SI,Lee AY,Lee YM,et al.Electrospun gelatin/poly(L-lactide-co-ε-caprolactone) nanofibers for mechanically functional tissue-engineering scaffolds.Journal of Biomaterials Science. Polymer Edition.2008,19(3): 339-357.
[66]Hadaschik BA,Paterson RF,FazliL,et al.Investigation of a novel degradable ureteral stent in a porcine model. J Urol.2008,180(3):1161-1166.
[67]Beiko DT,Knudsen BE,Denstedt JD. Advances in ureteral stent design J Endourol.2003,17(4):195-199.
[68]Lumiaho J.Heino A, Kauppinen T,et al.Drainage and antireflux characteristics of a biodegradable self-reinforced, self-expandingX-ray-positive poly-L, D-lactide spiral partial ureteral stent:an experimental study.J Endourol.2007, 21(12):1559-1564.
[69]Olweny EO,Portis AJ,Sundaram CP,et al.Evaluation of achronic indwelling prototype mesh ureteral stent in a porcine model.Urology.2000,56(5):857-862.
[70]Liatsikos EN,Hom D,Dinlenc CZ,et al.Tail Stent versusreentry tube:A randomized comparison after percutaneous stone extraction.Urology,2002,59 (1):15-19.
[71]Mardis HK.Standard specification for ureteral stents:A comparative evaluation of newer devices.J Urol,2001,165(suppl):362.
[72]Taylor WN,McDougall IT.Minimally invasive ureteral stent retrieval.J Urol.2002,168(5):2020-2023.
[73]Ecke TH,Bartel P,Hallmann S,Ruttloff J.Evaluation of symptoms and patients's comfort for JJ-ureteral stents with and without antireflux-membrane valve. Urology.2010,75:212-216.
[74]Beiko DT, Knudsen BE. Watterson JD, Cadieux PA, Reid G, Denstedt JD. Urinary tract biomaterials. J Urol.2004,171:2438-2444.
[75]Chew BH, Denstedt JD. Technology inside:novel ureteral stent materials and designs. Nat Clin Pract Urol.2004,1:44-48.
[76]Tolley D.Ureteric stents, far from ideal. Lancet.2000,356:872-873.
[77]Watterson JD, Cadieux P, Denstedt JD. Ureteral stents:which, when, and why? AUA Update Series.2002,21(16):122.
[78]Tunney MM, Gorman SP. Evaluation of a poly(vinyl pyrrolidone)-coated biomaterial for urological use. Biomaterials.2002,23:4601-4608.
[79]Stickler DJ, Evans A, Morris N, et al. Strategies for the control of catheter encrustation. Int J Antimicrob Agents.2002,19:499-506.
[80]Riedl CR, Witkowski M, Plas E, Plueger H. Heparin coating reduces encrustation of ureteral stents:A preliminary report. Int J Antimicrob Agents. 2002,19:507-510.
[81]Watterson JD, Cadieux PA, Beiko DT, et al.Oxalatedegrading enzymes from Oxalobacter formigenes:a novel device coating to reduce urinary tract biomaterial-related encrustation. J Endourol.2003,17:269-274.
[82]Laube N, Klienen L, Bradenahl J, et al. Diamond-like carbon coatings on ureteral stents-a new strategy for decreasing the formation of crystalline bacterial bioilm? J Urol.2007,177:1923-1927.
[83]Cormio L,Vuopio-Varkila J,Siitonen A etal.Bacterial adhesion and biofilm formation on various double-J stents in vivo and in vitro.Scand J Urol Nephro.1996,130:19
[84]Moulinier F.Comparison of biomaterial urinary encrustation in human implantation and in three experimental models.Br J U [Suppl].1997,80:302.
[85]Tunney MM,Keane PF,Jones DS et al.Comparative assessment of ureteral stent biomaterial encrustation.Biomaterials.1996,17:1541.
[86]Tunney MM,Bonner MC,Keane PF et al.Development of a model for assessment of biomaterial encrustation in the upper urinary tract.Biomaterials. 1996,17:1025.
[87]Tunney MM,Keane PF,Gorman SP.Assessment of urinary tract biomaterial encrustation using a modified Robbins device continuous flow model.J Biomed Mater Res.1997,38:87.
[88]Hedelin H,Grenabo L,Pettersson S.The effects of glycosaminoglycans, pyrophosphate and allopurinol treatment on urease-induced crystallization in vitro.UrolRes.1986,14:305.
[89]Wang YH,Grenabo L,Hedelin H et al.Citrateand urease-induced crystallization in synthetic and human urine.Urol Res.1993,21:109.
[90]Hedelin H,Grenabo L,Hugosson J et al.The influence of zinc and citrate on urease-induced urine crystallisation.Urol Res.1989,17:177.
[91]Choong SK,Wood S,Whitfield HN.A model to quantify encrustation on ureteric stents,urethral catheters and polymers intended for urological use.BJU Int.2000, 86:414.
[92]Painter DJ,Stickler DJ.A model to quantify encrustation on ureteric stents,urethral catheters and polymers intended for urological use.BJU Int.2001,87:716.
[93]Tieszer C,Reid G,Denstedt J.XPS and SEM detection of surface changes on 64 ureteral stents after human usage. J Biomed Mater Res.1998,43:321.
[94]Wood S.A novel method to measure ionized Mg2+and NH4+in undiluted urine:implications for stone formation.BJU Int.1997,84:156.